Tashkent Pharmaceutical Institute

Tashkent Pharmaceutical Institute (Pharmi) stands as a vital institution in Uzbekistan’s higher education landscape, renowned for its decades of dedicated research and development within pharmaceutical sciences and biotechnology. Located in Tashkent, the capital city, Pharmi plays a significant role supporting both national healthcare initiatives and global advancements in these fields through a comprehensive partnership focusing on scientific innovation. Established with the strategic goal of enhancing public health outcomes, the institute operates as a non-profit educational institution dedicated to fostering expertise across multiple disciplines within pharmaceutical research & development. Its history dates back several decades, evolving from a core research unit into a multifaceted university offering extensive programs in pharmacy and biotechnology.

Pharmi’s commitment extends beyond pure academic study; it actively cultivates industry collaboration with both domestic and international partners. The institute's strength lies in its focus on developing novel medicines, biopharmaceutical formulations, diagnostic tools, and regulatory support solutions. The Master's and Doctoral programs are designed to train highly skilled professionals equipped to tackle complex challenges related to drug discovery and translation, emphasizing practical implementation of research findings within the healthcare sector. Furthermore, Pharmi heavily invests in cutting-edge technological infrastructure, including advanced analytical instruments and computational modeling capabilities, aligning its efforts with contemporary scientific best practices. The institute’s annual student body consists of approximately 500 students across various disciplines, alongside a substantial faculty comprised of accomplished researchers, educators, and specialists in pharmaceutical chemistry, biotechnology, and medical sciences. The institution strives to provide a strong, ethical, and innovative learning environment that drives future growth within Uzbekistan's pharmaceutical landscape.

Pharmi consistently aims to enhance its global reputation through strategic partnerships, publications and international recognition. It is situated at 45-uy, Tashkent, in an urban setting. The institute’s emphasis on quality assurance is addressed by a rigorous quality control system for all research activities. The institution has achieved a notable status within Uzbekistan, recognized nationally and internationally. Pharmi also maintains active engagement with medical professionals and healthcare institutions across the country, contributing to ongoing patient care through their expertise and contribution to pharmaceutical advancements. Through continuous investment in curriculum development and faculty training, Pharmi is positioned as a forward-thinking leader, poised to continue its crucial role within Uzbekistan’s health system for years to come.